ARTICLE | Management Tracks
Senda hires COO and general counsel
Plus Raineri becomes CTO at Aspen, and updates from Evozyne, Nabsys, AnHeart and IDSA
October 20, 2022 12:32 AM UTC
Flagship-backed company Senda Biosciences Inc. hired Lori Rudolph-Owen as COO and Barbara Bispham as SVP, general counsel. Rudolph-Owen was chief development officer at Goldfinch Bio Inc., before which he was VP of portfolio management and assessment at Tesaro Inc. Bispham was VP, head of legal at BridgeBio Pharma Inc. (NASDAQ:BBIO).
Aspen Neuroscience Inc. hired Kim Raineri as CTO. Raineri was chief manufacturing and technology officer at Avrobio Inc. (NASDAQ:AVRO). Aspen is aiming to advance its autologous stem cell-derived Parkinson’s disease therapy into clinical trials next year...